Population
Valvular interstitial cells (VICs)
Design
Preclinical
Authors
Loading...
DPP-4 inhibition merits exploration in calcific aortic valve disease; leaves open human therapeutic translation.
DPP-4 promotes aortic valve calcification by inhibiting IGF-1 signaling in valvular interstitial cells, identifying it as a potential therapeutic target for calcific aortic valve disease.
Choi et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: